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Abstract 31 
Ubiquitin-modification is counteracted by deubiquitinating enzymes (DUBs). Here we identify 32 
USP8 as a novel component of the TCR signalosome that interacts with the adapter 33 
molecule GADS and 14-3-3β. Upon TCR-stimulation USP8 is processed in a caspase-34 
dependent manner. T-cell-specific deletion in mice (USP8f/fCD4-Cre) revealed that USP8 is 35 
essential for thymocyte transition to the CD4+ and CD8+ single positive stages and critical for 36 
TCR and Foxo1-mediated IL7Rα upregulation. In vivo reconstitution showed that enzymatic 37 
activity and SH3-binding are essential for USP8 function in T-cells. USP8f/fCD4-Cre mice 38 
develop lethal colitis promoted by disturbed T-cell homeostasis, predominance of CD8+ γδ-T-39 
cells in the intestine and impaired regulatory T-cell function. Collectively, these data reveal 40 
an unexpected role of USP8 as an immunomodulatory DUB in T-cells. 41 
  42 
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Introduction 43 
Ubiquitination plays a fundamental role in the immune system, but the physiological 44 
relevance of the more than 90 mammalian deubiquitinating enzymes (DUBs) is poorly 45 
defined1, 2, 3, 4. USP8 (synonym: UBPY) participates in endosomal sorting of transmembrane 46 
proteins5, 6 and interacts with the SH3 domain of signal transducing adapter molecule 2 47 
(STAM2), which is a component of the early acting endosomal sorting complex required for 48 
transport-0 (ESCRT-0)7. USP8 has been shown to deubiquitinate both cargo and ESCRT-0 49 
proteins thus modulating their function and stability5, 6. Proteolytic cleavage of human USP8 50 
was recently reported to increase its enzymatic activity and somatic mutations associated 51 
with increased processing were shown to cause Cushing´s disease by impairing EGFR 52 
downregulation8. 53 
USP8 contains two atypical SH3 binding motifs (SH3BMs) flanking a binding motif for 54 
14-3-3 proteins (14-3-3BM), which were shown to inhibit USP8 activity7, 8, 9, 10. Peptide 55 
binding studies revealed that the N-terminal USP8 SH3BM binds even stronger to an SH3-56 
domain of the GRB2-related adaptor downstream of Shc (GADS) than the C-terminal USP8 57 
SH3BM binds to the STAM2 SH3-domain11, 12. GADS is predominantly expressed in T-cells 58 
and acts proximal to the T-cell receptor (TCR) to modulate signal diversification13. GADS 59 
forms a constitutive adaptor complex with the SH2 domain-containing leukocyte protein of 76 60 
kDa (SLP76). Upon TCR activation GADS also associates with linker for activation of T-cells 61 
(LAT). However, it is unresolved, whether GADS interacts with USP8 in vivo. Furthermore, 62 
the function of USP8 in T-cells is entirely undefined.  63 
In T-cells several ubiquitin E3 ligases like Casitas B-cell lymphoma-b (Cbl-b), ITCH, 64 
gene related to anergy in lymphocytes (GRAIL), and Roquin are essential for the induction of 65 
anergy. As a consequence, loss of these proteins is associated with autoimmunity2, 14. 66 
Likewise, several DUBs, like A20, USP9X, USP15, and Cylindromatosis (CYLD) were shown 67 
to be essential for proper T-cell function1, 4, 15, 16. Upon overexpression, USP8 was reported to 68 
form a complex with GRAIL and the DUB otubain117. It was speculated that complex 69 
formation with an inactive isoform of otubain1 enables USP8 to deubiquitinate and stabilize 70 
GRAIL.  71 
Besides TCR-mediated signals, T-cell function and development is controlled by 72 
cytokines and chemokines, which transmit signals through their cognate receptors. A tightly 73 
regulated key player in lymphocyte development and function is the interleukin-7 receptor 74 
(IL-7R), which is transiently downregulated on CD4+CD8+ double-positive (DP) thymocytes 75 
and re-expressed by CD4+ and CD8+ single positive (SP) thymocytes. In the periphery, it is 76 
highly expressed by naïve T-cells18. Forkhead box O1 (Foxo1) is a critical transcription factor 77 
positively controlling IL-7Rα expression19, 20. Foxo1 also directly or indirectly affects 78 
expression of Kruppel-like factor 2 (KLF2), CC-chemokine receptor 7 (CCR7) and CD62L19, 79 
4 
 
21. In addition, Foxo1 controlled transcription programs were shown to be essential for 80 
regulatory T-cell (Treg) function22. Foxo1 itself is regulated by posttranslational modifications 81 
and sequestration by 14-3-3 proteins23, 24. 82 
Defects in TCR signaling or thymocyte development often cause chronic 83 
lymphopenia, which typically results in a proliferative response and conversion of T-cells 84 
from a naïve to an effector phenotype21, 25. IL-7R signaling and self-peptide-MHC complexes 85 
are vital for lymphopenia-induced proliferation and naïve T-cell homeostasis21, 25. 86 
Furthermore, altered T-cell homeostasis predisposes to the development of colitis typically 87 
promoted by defective Treg function20, 26. 88 
Here we show that USP8 represents a novel GADS and 14-3-3β-interacting protein 89 
that is processed upon TCR activation in a caspase-dependent manner. Furthermore, we 90 
provide evidence that USP8 is essential for normal T-cell development and homeostasis by 91 
securing maturation and Foxo1-mediated upregulation of IL7Rα. Concordantly, T-cell-specific 92 
inactivation of USP8 resulted in lethal colitis associated with dysfunction of Tregs towards 93 
highly abundant CD8+ γδ T-cells in inflamed colons. These data establish USP8 as a novel 94 
DUB playing a key role in T-cell development and homeostasis. 95 
   96 
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Results 97 
USP8 interacts with GADS and is proteolytically processed upon TCR stimulation 98 
To identify potential USP8-interacting proteins in T-cells, a yeast two-hybrid (Y2H) screen 99 
was performed using fragments of USP8 as baits and a thymocyte-derived cDNA library. Bait 100 
1 harboring the N-terminal SH3BM of USP8 yielded GADS as a binding partner. 101 
Furthermore, 14-3-3β was detected using bait 2, encompassing the 14-3-3BM of USP8 102 
(Supplementary Fig. 1). 103 
Interactions were confirmed in coimmunoprecipitation experiments with exogenously 104 
expressed, affinity-tagged proteins (Fig. 1a and b). To analyze the contribution of the USP8 105 
SH3BMs to the interaction with GADS, critical proline residues were replaced by alanine 106 
(P405A, P738A and P405A/P738A). Replacement of the N-terminal proline (P405) 107 
significantly diminished USP8 binding to GADS (Fig. 1a). The interaction with 14-3-3 proteins 108 
depends on phosphorylation of a serine within the binding motif. To evaluate the role of the 109 
USP8 14-3-3BM, the critical serine within this motif was replaced by alanine (S718A)9. 110 
Replacement of S718 abolished binding to 14-3-3β indicating that USP8 binds to 14-3-3β in 111 
a phospho-S718-dependent manner (Fig. 1b). Constitutive interaction of endogenous GADS 112 
and USP8 was confirmed in T-cells upon immunoprecipitation of endogenous USP8 (Fig. 113 
1c). Furthermore, endogenous 14-3-3β interacted with FLAG-tagged wild type (WT) USP8, 114 
but not USP8(S718A) (Fig. 1d). 115 
Individual TCRs are hypothesized to form nanoclusters in the absence of stimulation 116 
and to form microclusters upon activation27. As GADS and 14-3-3 proteins represent well-117 
established proximal components of TCR signaling13, 28, we asked whether USP8 might also 118 
participate. We therefore restimulated ex vivo grown CD4+ T-cells with beads coupled to anti-119 
CD3 and anti-CD28 antibodies, which trigger TCR- and costimulation simultaneously and 120 
allow the precipitation of TCR/CD28-associated proteins. USP8 and GADS were indeed 121 
identified to bind to the TCR/CD28 cluster and co-accumulate upon stimulation (Fig. 1e). 122 
Intriguingly, upon TCR stimulation USP8 was proteolytically processed leading to the 123 
generation of an N-terminal 70 kDa cleavage product (Fig. 1f). USP8 cleavage was inhibited 124 
by pan-caspase inhibitor z-VAD pretreatment, indicating that USP8 is regulated in a 125 
caspase-dependent manner (Fig. 1g).  126 
To evaluate whether GADS and 14-3-3β are modified by ubiquitin and might 127 
represent substrates for USP8-mediated deubiquitination, these proteins were coexpressed 128 
with WT USP8 or the USP8(C786A) variant lacking deubiquitinating activity. Consistent with 129 
ubiquitin modification, bands of higher molecular mass were detected for GADS and 14-3-3β 130 
upon coexpression and immunoprecipitation with USP8(C786A), but not WT USP8 (Fig. 1h). 131 
USP8-mediated modulation of GADS and 14-3-3β ubiquitination was confirmed by 132 
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coexpression of FLAG-tagged ubiquitin (Supplementary Fig. 2a). Furthermore, 133 
ubiquitination of 14-3-3β at lysines 9 and 189 was identified by mass spectrometry 134 
(Supplementary Fig. 2b).  135 
In summary, our results provide strong evidence that USP8 interacts with GADS and 136 
TCR signalosomes. We show that 14-3-3β interacts with USP8 via the 14-3-3BM in a serine 137 
phosphorylation-dependent manner. Our data suggest that GADS and 14-3-3β represent 138 
USP8 substrates, whereas USP8 is a target of caspase-dependent regulation. 139 
 140 
USP8 is essential for T-cell development 141 
To analyze the physiological role of USP8 in T-cells, USP8fl/fl mice 5 were mated to CD4Cre-142 
transgenic mice. Deletion of USP8 in DP and CD4+ SP (SP4) USP8f/fCD4-Cre thymocytes 143 
was confirmed by Southern and/or Western blot (WB) analyses (Fig. 2a, Supplementary 144 
Fig. 3a and 3b). However, CD8+ SP (SP8) thymocytes showed no reduction of USP8 145 
expression (Supplementary Fig. 3b) presumably due to an advantage of escapees that 146 
reach an immature developmental stage without losing USP8 protein expression. 147 
Accordingly, USP8f/fCD4-Cre mice exhibited significantly reduced percentages of SP4 and 148 
SP8 thymocytes resulting in a 2-3.5 fold decrease in total numbers, whereas total numbers of 149 
DP thymocytes were unaltered. Moreover, the reduction of SP8 thymocytes was even more 150 
pronounced within the TCRhi subpopulation (Fig. 2b). In agreement with a developmental 151 
defect in the transition from DP to SP thymocytes, medullary regions were sparsely 152 
distributed and smaller in thymi of USP8f/fCD4-Cre mice (Fig. 2c). Furthermore, the 153 
percentage of CD25+Foxp3+ Tregs among the CD4+ cell population and the NK1.1+ NKT-cell 154 
population were diminished (Fig. 2d). To characterize CD4-CD8- double negative (DN), DP, 155 
SP4 and SP8 thymocytes, developmental markers were analyzed (Fig. 2e). TCRβ 156 
expression among SP4 and SP8 USP8f/fCD4-Cre cells was diminished. While CD62L 157 
expression was reduced in SP4 cells, lower percentages of SP8 cells expressed CD5. CD24 158 
downregulation, which also correlates with progressed maturation, was not observed in 159 
USP8f/fCD4-Cre SP4 and SP8 cells. Higher percentages of USP8f/fCD4-Cre SP4 cells 160 
strongly expressed CD69, indicating that more cells are engaged in early acting TCR-pMHC 161 
interactions29. Likewise, when USP8f/fLCKCre mice30 were used, the USP8 protein depletion 162 
pattern was similar as in USP8f/fCD4-Cre mice and did not reveal a defect in DN cell 163 
development (Supplementary Fig. 3c and 3d). However, a similar shift in SP4 and SP8 164 
thymocyte populations and TCRβ expression as upon CD4Cre-mediated deletion was 165 
observed (Supplementary Fig. 3e). Taken together, these results show that USP8 is critical 166 
for thymocyte maturation. 167 
 168 
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USP8 is required for proliferation and IL-2 production, but not for negative selection of 169 
thymocytes 170 
Ex vivo, lack of USP8 compromised thymocyte proliferation upon anti-CD3 stimulation in the 171 
absence or presence of IL-2 or anti-CD28 costimulation. Defects in proliferation were also 172 
observed when cells were stimulated with PMA/IONO, which bypasses proximal TCR 173 
signaling, indicating that lack of USP8 also affects downstream processes. Lack of 174 
proliferation was accompanied by diminished TCRβ expression (Fig. 3a). Differences in 175 
thymocyte apoptosis were not detected (Supplementary Fig. 3f). In addition, anti-CD3-176 
stimulated USP8f/fCD4-Cre thymocytes were unable to secrete IL-2 (Fig. 3b). 177 
Qualitative alterations of T-cell signaling were previously shown to influence positive 178 
or negative selection within the thymus. For example, GADS knockout (KO) mice display 179 
defects in negative selection31. To analyze a potential role of USP8 in thymic selection, 180 
USP8f/fCD4-Cre mice were crossed to HY-TCR transgenic mice expressing a transgenic 181 
TCR recognizing the male tissue-specific HY antigen. Similar to the situation in USP8f/fCD4-182 
Cre animals, percentages of mature SP4 or SP8 thymocytes were reduced in USP8f/fCD4-183 
CreHY-TCR+ female animals (Fig. 3c, upper panels). However, negative selection in male 184 
animals was not compromised in the absence of USP8 (Fig. 3c, lower panels). 185 
 186 
Lack of USP8 impairs IL7Rα and CCR7 expression and Foxo1 activity 187 
Unlike USP8-deficient mouse embryonic fibroblasts (MEFs) and hepatocytes5, USP8f/fCD4-188 
Cre thymocytes did not display differences in the stability of STAM2 or overall ubiquitination 189 
compared to USP8f/f controls (Supplementary Fig. 4a and b). Moreover, endocytosis of the 190 
TCR upon stimulation was unaffected by the loss of USP8 (Supplementary Fig. 4c). These 191 
results suggest that the function of USP8 in T-cells differs from the previously described 192 
ESCRT-associated role in MEFs and hepatocytes. Furthermore, MAPK, Akt and IκB 193 
activation/phosphorylation, and IκB degradation in response to TCR stimulation, protein 194 
stability of 14-3-3β or GADS, NF-κB and activator protein 1 (AP-1) DNA-binding, overall 195 
tyrosine phosphorylation, and calcium influx were not altered in USP8f/fCD4-Cre thymocytes 196 
(Supplementary Fig. 4d-j). These results suggest that USP8 is dispensable for canonical 197 
TCR signaling. 198 
To detect primary alterations in USP8-deficient thymocytes, RNA expression profiles 199 
of DP thymocytes were analyzed by microarray analysis. Around 74 genes were 200 
dysregulated more than two-fold. Interestingly, IL7Rα mRNA showed the strongest 201 
downregulation in the absence of USP8 (Supplementary Fig. 5a). Ingenuity pathway 202 
analysis revealed a prominent network that centers around IL7Rα and Cyclin D2 expression 203 
(Supplementary Fig. 5b). Concordantly, upregulation of IL7Rα surface expression was 204 
impaired in USP8f/fCD4-Cre SP thymocytes and IL7Rα mRNA expression levels were 205 
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decreased at the preceding DP stage of development (Fig. 4a). Similarly, CCR7 mRNA was 206 
found to be downregulated in USP8f/fCD4-Cre DP thymocytes and CCR7 protein 207 
upregulation was blocked in SP4 thymocytes (Fig. 4a). However, a fraction of cells exhibited 208 
normal IL7Rα and CCR7 expression levels consistent with incomplete deletion (see 209 
Supplementary Fig. 3b). IL7Rα, CCR7 and CD62L (see Fig. 2e) constitute direct or indirect 210 
target genes of the transcription factor Foxo1, which is known to be regulated by 14-3-3 211 
proteins23, 24. Thus, we speculated that the defect in expression of these genes might arise 212 
from a defect in Foxo1 stability or activity caused by the lack of USP8. Whereas Foxo1 213 
protein levels and relocalization in response to TCR stimulation were unaltered in the 214 
absence of USP8 (Fig. 4b and data not shown), Chromatin immunoprecipitation (CHIP) 215 
analysis revealed that Foxo1 binding to the IL7Rα promoter is severely compromised in 216 
USP8f/fCD4-Cre thymocytes (Fig. 4c). These results indicate that USP8 directly or indirectly 217 
affects thymocyte development via the Foxo1-IL7R axis. 218 
 219 
USP8 is critical for T-cell homeostasis  220 
Consistent with the defect in thymocyte development, the percentages of SP4 and SP8 T-221 
cells and total T-cell numbers in spleen and mesenteric lymph nodes (MLNs) of USP8f/fCD4-222 
Cre mice were strongly reduced (Fig. 5a, Supplementary Fig. 6a and data not shown). 223 
Southern blot analysis revealed that USP8 gene deletion in peripheral T-cells is incomplete 224 
indicating that cells which failed to delete USP8 have an advantage in the periphery 225 
(Supplementary Fig. 6b). Naïve CD4+ T-cells were strongly reduced in the periphery of 226 
USP8f/fCD4-Cre mice and the percentages of CD44hi effector (CD62Llo) and memory 227 
(CD62Lhi) T-cells were elevated (Fig. 5a). Remaining effector T-cells were identified to 228 
represent escapees of USP8 deletion (Supplementary Fig. 6c). IL-7Rα expression was 229 
reduced in the few remaining naïve T-cells, but not in effector T-cells (Supplementary Fig. 230 
6d). LCKCre-mediated deletion of USP8 also caused a severe reduction of the percentages 231 
of T-cells in the periphery, pronounced diminishment of the naïve T-cell population and a 232 
decrease in IL-7Rα expression on naïve T-cells (Supplementary Fig. 6e).  233 
CCR7 expressing CD4+ cells were also almost absent in the periphery of USP8f/fCD4-Cre 234 
mice (Supplementary Fig. 6f). In spleen, no significant differences in the percentages of 235 
Tregs (relative to the CD4+ population), granulocytes, monocytes, plasmacytoid dendritic 236 
cells (pDCs), or conventional DCs (relative to CD3- populations) were observed (Fig. 5b). 237 
The percentages of Tregs relative to the CD4+ population and of pDCs were significantly 238 
increased in MLNs (Fig. 5c). However, due to the decrease in overall T-cell numbers also 239 
total numbers of Tregs were reduced. A higher percentage of CD4+ USP8f/fCD4-Cre 240 
splenocytes produced interferon γ (IFNγ) and IL-17 after PMA/IONO stimulation (Fig. 5d). 241 
Moreover, percentages of cells expressing the activation markers CD25 and CD69 were 242 
9 
 
increased among peripheral USP8f/fCD4-Cre CD4+ T-cells. Concordantly, expression of the 243 
negative activation markers CD45RB and TCRβ was diminished in spleen and expression of 244 
TCRβ was reduced in MLNs (Fig. 5e). These results show that USP8 is critical for T-cell 245 
homeostasis in vivo. 246 
 247 
CD4Cre-mediated deletion of USP8 causes lethal colitis 248 
Intriguingly, USP8f/fCD4-Cre mice spontaneously developed colitis. Pathological and 249 
endoscopic analysis revealed colon thickening and inflammation emanating from the distal 250 
part of the colon resulting in enhanced granularity, loss of the vascular pattern of the mucosa 251 
and a reduction in translucency. Frequently, intestinal prolapses were observed. Colitis was 252 
typically accompanied by lymphadenopathy and splenomegaly (Fig. 6a and movies S1/S2). 253 
Starting from week 6, animals became moribund and died within 20 weeks with almost 100% 254 
penetrance (Fig. 6b). Histological analysis showed thickening of the mucosa, cryptic 255 
abscesses, cellular infiltrates, epithelial hyperplasia and elongated crypts (Figure 6c, upper 256 
left panels). Intriguingly, among infiltrating cells a large portion were CD3+ T-cells. Foxp3+ 257 
Tregs were also detected (Figure 6c, lower left panels). Massive infiltrates of DCs, 258 
neutrophils and macrophages were present in inflamed colon sections of USP8f/fCD4-Cre 259 
mice (Fig. 6c, right panels). Splenomegaly was characterized by a reduced size of the 260 
periarteriolar lymphoid sheaths and concomitant enlargement of the Ki-67 positive red pulp 261 
compartment containing Mac-3+ myeloid cells (Fig. 6d). 262 
 263 
USP8 is an intrinsic regulator of T-cell development and homeostasis 264 
To analyze the function of USP8 in mature T-cells irrespective of phenotypes through 265 
modified thymocyte development, we crossed USP8f/f animals to transgenic mice expressing 266 
tamoxifen-inducible Cre specifically in CD4+ T-cells (USP8f/fCD4-CreERT2)32. To restrict 267 
USP8 deletion to peripheral T-cells, RAG2/Il2rg double deficient mice were reconstituted with 268 
splenocytes derived from USP8+/+CD4-CreERT2 or USP8f/fCD4-CreERT2 mice. Tamoxifen-269 
induced deletion of USP8 caused a significant reduction of CD4+ splenocytes and 270 
CD44loCD62Lhi CD4+ T-cells, demonstrating that USP8 is essential for the maintenance of 271 
the naïve CD4+ T-cell pool (Fig. 7a). To test whether USP8-deficient T-cells have an intrinsic 272 
defect in thymocyte development and peripheral T-cell homeostasis, or whether the defect(s) 273 
can be overcome by the presence of WT T-cells, we generated CD45.1+WT/CD45.2+USP8f/f 274 
and CD45.1+WT/CD45.2+USP8f/fCD4-Cre BM chimeras. Even in the presence of WT 275 
thymocytes and peripheral T-cells, CD45.2+USP8f/fCD4-Cre T-cells exhibited a defect in 276 
thymocyte development and expansion/survival in the periphery accompanied by a shift 277 
towards effector/memory populations (Fig. 7b). This shift was less severe than in 278 
USP8f/fCD4-Cre mice (% naive CD4+CD44loCD62Lhi T-cells: 15.45±3.95 versus 3.22±0.83, 279 
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p<0.01, unpaired, 2-sided t-test)  (see also Fig. 5a), indicating that the effect partially 280 
depends on lymphopenia-induced homeostatic expansion most likely caused by escapees of 281 
USP8 deletion. In addition, more peripheral USP8f/fCD4-Cre T-cells produced IFNγ and IL-17 282 
upon PMA/IONO treatment. Altogether, these findings demonstrate that USP8 is an intrinsic 283 
regulator of both thymocyte development and peripheral T-cell homeostasis.  284 
Likewise, we investigated whether reduced IL7-R expression is a cell intrinsic 285 
consequence of the USP8 defect. IL7Rα surface expression was impaired in CD45.2+ 286 
USP8f/fCD4-Cre SP thymocytes suggesting that here USP8 depletion directly affects IL7Rα 287 
expression. In peripheral CD45.2+ USP8f/fCD4-Cre naïve T-cells of competitive BM chimeras, 288 
IL7Rα expression was not decreased. Therefore, reduced IL-7Rα expression on naïve T-289 
cells as seen in the non-competitive background appears to be caused by extrinsic 290 
mechanisms. Homeostatic expansion of cells which failed to delete USP8 probably accounts 291 
for this effect (Supplementary Fig. 6g). 292 
 293 
USP8 is dispensable for canonical TCR signaling in peripheral T-cells 294 
As the dramatic reduction of the naïve T-cell population in USP8f/fCD4-Cre mice hampered 295 
further analysis, we took advantage of the 4-hydroxytamoxifen (OHT)-inducible CreERT2 296 
system to analyze signaling in T-cells upon deletion of USP8 before manifestation of 297 
secondary effects on cell proliferation and CD3 expression. We found maximum suppression 298 
of USP8 protein expression in cultured USP8f/fCD4-CreERT2 CD4+ T-cells 48h post OHT 299 
addition (Fig. 7c, upper panels), whereas a reduction of CD3 and Ki67 expression became 300 
apparent starting at 72h post OHT addition (Fig. 7c, lower panels). We therefore 301 
restimulated CD4+ T-cells 48h after OHT treatment with anti-CD3/anti-CD28 antibodies and 302 
monitored phosphorylation/activation state and expression of an array of signaling 303 
molecules. LAT and PLCγ phosphorylation was high in unstimulated cells of both genotypes 304 
and was downregulated upon restimulation, which correlated with normal ERK1/2 activation 305 
(Supplementary Fig. 7a). Moreover, GADS and 14-3-3β expression, IκB, p38 and PKB 306 
phosphorylation, global K48-linked ubiquitination, tyrosine-, SLP76(S376)- and JNK-307 
phosphorylation, and Foxo1 and GRAIL protein levels were unaltered (Supplementary Fig. 308 
7b-d). Because USP8 was shown to regulate endosomal trafficking, we next asked whether 309 
the protein is involved in proper assembly of the TCR signalosome upon activation, which 310 
has been hypothesized to involve the recruitment of subcellular LAT-containing vesicles13. In 311 
agreement with normal LAT phosphorylation, recruitment of signaling molecules including 312 
14-3-3β correlated with the amount of CD3 in the purified complexes (Supplementary Fig. 313 
8a). Furthermore, the amount of the overall complex purified upon TCR stimulation did not 314 
differ significantly in four independent experiments. In summary, these data strongly suggest 315 
that similar to thymocytes USP8 is dispensable for canonical CD3/CD28-induced receptor-316 
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proximal signaling in mature T-cells. As shown in Jurkat-derived KO cell lines, lack of SLP76 317 
did not influence USP8 co-accumulation with the TCR/CD28 cluster, whereas LAT was 318 
crucial for signalosome formation. However, USP8 binding was not abolished in the absence 319 
of GADS (Supplementary Fig. 8b) suggesting that other interaction partners or motifs of 320 
USP8 contribute to the binding to the signalosome. Furthermore, our results show that USP8 321 
also interacts with the TCR/CD28 cluster in human cells. 322 
 323 
Catalytic activity and SH3 binding capacity are crucial for the function of USP8 in T-324 
cells 325 
To gain mechanistic insight into structure-function relationships of USP8 in T-cells, we used 326 
an in vivo rescue approach. To this end, USP8f/fCD4-Cre BM stem cells were reconstituted 327 
with retroviruses ectopically expressing EGFP in combination with either WT USP8 or 328 
variants lacking either catalytic activity (C748A), SH3 binding capacity (P405/700A) or the 329 
phosphorylation site required for 14-3-3 binding (S680A). Subsequently, these cells were 330 
transplanted into lethally irradiated RAG1-deficient recipients and the distribution of splenic 331 
T-cell subsets was analyzed 8 weeks later. Reconstitution with either an empty vector or the 332 
USP8 variant lacking isopeptidase activity entirely failed to rescue T-cell development (Fig. 333 
7d). Likewise the USP8 variant which lacks the SH3BMs and can no longer interact with 334 
GADS (see Fig. 1a) failed to restore the T-cell compartment. In contrast, cells expressing WT 335 
USP8 entirely restored the T-cell compartment and also the 14-3-3 binding mutant did not 336 
show significant defects in rescue capability (Fig. 7d). 337 
These results clearly show that both catalytic activity of USP8 and the SH3BMs but 338 
not 14-3-3 binding, are essential for USP8 function in T-cells. 339 
 340 
USP8 is necessary for Treg function against proinflammatory γδ T-cells 341 
The intraepithelial lymphocyte (IEL) population of the gut represents the 342 
environmental interface with the highest abundance of mostly CD8+ TCRΥδ+ T-cells33. IEL 343 
TCRΥδ+ T-cells have been described previously to be responsible for intestinal inflammation 344 
in mice lacking phosphoinositide-dependent protein kinase 1 (PDK1) in T-cells26. PDK1 acts 345 
downstream of PI3K and is also crucial for the maintenance of functional Tregs. Because our 346 
histological analysis revealed disproportional high recruitment of CD3+ T-cells to inflamed 347 
colons of lymphopenic USP8f/fCD4-Cre mice, we examined whether these cells are TCRαβ- 348 
or TCRΥδ-positive. Indeed, our results show that CD8+TCRΥδ+ T-cells are the main T-cell 349 
population among USP8f/fCD4-Cre IELs in inflamed colons (Fig. 8a). In contrast to 350 
USP8f/fCD4-Cre TCRαβ+ T-cells, surface expression of the activation marker CD69 was not 351 
compromised in TCRΥδ+ T-cells (Fig. 8a). Elevated percentages of CD8+ TCRΥδ+ T-cells 352 
were also found in MLNs of USP8f/fCD4-Cre mice (Fig. 8b). More USP8f/fCD4-Cre TCRαβ+ T-353 
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cells expressed CD69 in MLNs, which is consistent with the data shown in Fig. 5e. We found 354 
that the numbers of γδ T-cells were 8-10-fold higher in MLNs of both, USP8f/fCD4-Cre (Fig. 355 
8c) and USP8f/fLCKCre mice (data not shown), and 4-fold in the USP8f/fCD4-Cre T-cell 356 
population of mixed BM chimaera (Fig. 8c). Furthermore, quantification of blood cytokine 357 
levels revealed that the pro-inflammatory cytokines IL-6 and IL-12p70 were significantly 358 
elevated in the serum of diseased USP8f/fCD4-Cre mice. Elevated levels of IFNγ and TNFα 359 
were also detected in these mice, whereas upregulation of IL-10 and IL-17 was not observed 360 
(Fig. 8d and data not shown). To examine whether USP8 is crucial for the functional capacity 361 
of Tregs, we performed an in vivo Treg assay. Our results demonstrate that co-injection of 362 
USP8f/fCD4-Cre Tregs does not prevent the onset of colitis in Rag1-/- mice that were 363 
reconstituted with naïve CD4+ WT cells (Fig. 8e). USP8-deficient Treg cells were also less 364 
effective than control Treg cells in inhibiting naïve T-cell proliferation in vitro (Fig. 8f). For 365 
Treg-specific Foxo1 KO cells it has been shown that lack of function is caused by a 366 
deregulated IFNγ response22. Likewise, we observed an increased IFNγ response in USP8 367 
depleted Tregs (Fig. 8g). These data demonstrate that USP8 is required for the maintenance 368 
of enteric immune tolerance by Treg cells via suppression of an inflammatory response 369 
mediated by intestinal γδ T-cells. 370 
371 
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Discussion 372 
Here we show that the DUB USP8 is a previously unidentified component of the TCR 373 
signaling complex interacting with GADS and 14-3-3β. Previous studies have shown that a 374 
peptide comprising the conserved C-terminal SH3BM in USP8 binds the STAM2-SH312. 375 
Intriguingly, a peptide derived from one of the two GADS-SH3 domains binds to the N-376 
terminal USP8 SH3BM with more than 25fold higher affinity11. This is consistent with our 377 
observation that GADS was detected in our Y2H screen by the bait encompassing the N-378 
terminal SH3BM of USP8. As GADS expression is largely restricted to lymphocytes, high 379 
affinity binding to GADS might explain why, in contrast to MEFs and hepatocytes, STAM2 380 
stability and endosomal sorting appear unaffected in USP8-depleted T-cells5. Ectopic re-381 
expression of an USP8 mutant lacking the SH3BMs did not rescue T-cell development. This 382 
clearly shows that the SH3BM-mediated interactions are essential for the function of USP8 in 383 
T-cells and suggests that USP8/GADS-binding mediated by the atypical N-terminal SH3BM 384 
in USP8 is critical for the specificity of USP8 function in T-cells7, 11, 12. Our in vivo rescue 385 
experiments also demonstrate that the catalytic activity is essential for USP8 function in T-386 
cell development. This is of particular interest as different DUBs such as A20 or USP18 were 387 
shown to possess physiologically relevant non enzymatic functions34, 35, 36. 388 
Within this study we identified 14-3-3β as a binding partner of USP8. As typical for 14-389 
3-3 proteins, this interaction was dependent on a serine phosphorylation motif within the 14-390 
3-3BM of USP823. 14-3-3ε, λ, and ζ binding to USP8 was previously shown to exert an 391 
inhibitory effect on USP8 catalytic activity8, 9. Thus, serine phosphorylation-dependent 392 
binding of 14-3-3β might negatively regulate USP8 catalytic function in T-cells. Remarkably, 393 
upon TCR-stimulation USP8 gets cleaved by a caspase-dependent mechanism. Consistent 394 
with the resulting N-terminal 70kDa cleavage product observed in our study, a recent report 395 
showed that human USP8 mutants undergo proteolytic cleavage within the 14-3-3 binding 396 
region resulting in enhanced DUB activity8. Thus, it is well conceivable that 14-3-3β binding 397 
and proteolytic processing contrarily regulate USP8 DUB activity in a TCR stimulation 398 
dependent manner. 399 
Our findings strongly suggest that GADS and 14-3-3β represent substrates for USP8-400 
mediated deubiquitination. Unaltered stability in the absence of USP8 and a modification 401 
pattern typical for mono-ubiquitination indicates that USP8-mediated deubiquitination of 402 
GADS and 14-3-3 regulates protein complex composition rather than stability of these 403 
proteins. Interestingly, for both SLP76 and GADS, TCR-induced interactions with 14-3-3 404 
proteins have been described with the functional consequence of a negative feedback 405 
inhibition of TCR signaling and uncoupling from LAT28, 37. 406 
USP8 has previously been suspected to regulate the stability of GRAIL 38. However, 407 
we did not detect any differences in GRAIL stability in the absence of USP8. 408 
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CD4Cre- as well as LCKCre-mediated USP8 deletion caused a defect in SP 409 
thymocyte maturation. During SP thymocyte development, low-affinity TCR interactions with 410 
self-peptide-MHC trigger a signaling cascade that allows for positive selection13. Although our 411 
studies did not reveal any differences in negative selection or TCR-induced canonical 412 
signaling cascades, we cannot exclude that USP8 is involved in the discrimination of low- 413 
and high-affinity signals in specific cell populations. Likewise, USP8 may control TCR-414 
stabilization and upregulation during development. Thus, USP8 may indirectly influence 415 
thymocyte maturation and IL-7Rα upregulation. According to the kinetic signaling model of T-416 
cell development, cytokine receptor signals specify the lineage fate of MHC-I-selected 417 
thymocytes, whereas TCR signals specify the lineage fate of MHC-II-selected thymocytes39. 418 
Similar to T-cell-specific IL7R KO mice, USP8f/fCD4-Cre animals showed a marked reduction 419 
of SP8 cells among TCRβhi thymocytes. However, the defect in SP4 maturation suggests 420 
that IL7R-independent mechanisms are affected as well. 421 
Our data indicate that USP8 is critical for Foxo1 activity in thymocytes. USP8 422 
regulation of 14-3-3β ubiquitination may directly affect the potential of 14-3-3β to regulate 423 
Foxo1 DNA binding in the nucleus similar to what has been shown for the regulation of DAF-424 
16 and Foxo4 by 14-3-3 proteins23. High nuclear activity of Foxo1 was shown to be essential 425 
for Treg activity. Importantly, Foxo1 controls the expression of Foxp3 and a subset of Treg-426 
associated genes and is critical for the suppression of IFNγ expression, which is also 427 
compromised in USP8-deficient Tregs22, 40. Thus, impaired Foxo1 activity as detected in 428 
USP8-deficient thymocytes might provide an explanation for the compromised Treg function 429 
observed in USP8f/fCD4-Cre mice. Accordingly, in a bone marrow (BM) transfer model using 430 
sublethally irradiated Rag1-/- mice, lack of Foxo1 expression in T-cells resulted in colitis 431 
presumably due to defective Treg abundance and function20. Consistent with the gut 432 
representing the interface with the highest abundance of γδ T-cells, colitis in USP8f/fCD4-Cre 433 
mice was associated with a dysfunction of regulatory T-cells towards highly abundant CD8+ 434 
γδ T-cells in inflamed colons. γδ T-cells have already been shown to play an exacerbating 435 
role in chronic colitis in TCRα mutant mice and PDK1f/fCD4-Cre mice26, 41. 436 
In accordance with the phenotype displayed by T-cell-specific USP8 KO mice, T-cell-437 
specific deletion of the Foxo1 gene in mice led to defects in IL-7–dependent homeostatic 438 
proliferation in vivo as well as spontaneous T-cell activation and effector T-cell 439 
differentiation20, 42. In addition to defective Foxo1 regulation, the failure in IL-2 secretion and 440 
CCR7 upregulation in thymocytes and the observed lack of IL-10 up-regulation in diseased 441 
USP8f/fCD4-Cre mice could per se account for defective in vivo Treg function and/or 442 
susceptibility to colitis43, 44, 45. 443 
In conclusion, we have identified USP8 as a GADS-interacting DUB associated with 444 
the TCR signalosome. The previously undefined role of USP8 in T-cell development, immune 445 
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homeostasis and control of Foxo1 target gene expression may provide new avenues for the 446 
treatment of immunological disorders. 447 
  448 
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 449 
Methods 450 
Methods and any associated references are available in the online version of the paper. 451 
 452 
Note: Any Supplementary Information and Source Data files are available in the online 453 
version of the paper. 454 
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Material and Methods 476 
 477 
Mice. 478 
USP8f/f, RAG2/Il2rg double KO, CD4Cre-, CD4CreERT2-, LCKCre-, and HY-TCR transgenic 479 
mice have been described previously5, 30, 32, 46, 47, 48. Mice used for experiments were on the 480 
C57BL/6 background. Histological examinations of the colon and the survival studies with 481 
USP8f/fCD4-Cre mice were done on mixed C57BL/6-129OLA background. If not otherwise 482 
stated, 8-week to 3-month old, sex-matched littermates were used in all experiments. The 483 
survival study was performed with age- and sex-matched mice for the indicated observation 484 
period. Animals were housed in a specific pathogen-free barrier facility according to the 485 
protocols of the Center for Experimental Models and Transgenic Services (CEMT) at the 486 
University Clinic in Freiburg. All experiments were approved by national authorities (G-487 
10/101) and the ethics review board for animal studies at the University of Freiburg. 488 
 489 
Southern blotting and real-time PCR. 490 
WT, loxP-flanked and deleted USP8 alleles were identified by Southern blotting of NcoI 491 
fragments of genomic DNA as described before5. For real-time PCR, DP thymocytes were 492 
isolated by cell sorting and RNA was isolated using the RNeasy Mini Kit (Qiagen) following 493 
the manufacturer's instructions. Samples were treated with DNaseI (Roche) and RNA was 494 
transcribed into cDNA using oligo-dT primers and the SuperScript II RT kit (Invitrogen). RT-495 
PCR reactions were performed using LightCycler 480 SYBR Green I master mix (Roche) and 496 
the following primers: IL7Ra_S: TGGGGCTCTTTTACGAGTGA; IL7Ra_AS: 497 
TTGCTTCTTTGCGATAAACG; CCR7_S: TGATTTCTACAGCCCCCAGA; CCR7_AS: 498 
GCACACCTGGAAAATGACAA; Cyclin D2_S: GCGTGCAGAAGGACATCCA; Cyclin D2_AS: 499 
CACTTTTGTTCCTCACAGACCTCTAG; GAPDH_S: TCCTGCACCACCAACTGCTTAGCC; 500 
GAPDH_AS: GTTCAGCTCTGGGATGACCTTGCC. 501 
 502 
Cell preparation and flow cytometry. 503 
Thymi, spleens and MLNs were mashed into single-cell suspensions in PBS containing 1 % 504 
FCS and splenocytes were depleted of red blood cells using RBC lysis buffer (Sigma). Cell 505 
suspensions were incubated with mouse BD Fc Block™. CD4+ T-cells were enriched by the 506 
use of the mouse CD4 T lymphocyte enrichment set – DM from BD Biosciences or purified 507 
using BD IMag™ anti-mouse CD4 particles-DM (BD Biosciences). DP thymocytes were 508 
enriched using BD IMag™ anti-mouse CD8a particles-DM (BD Biosciences). BM from tibias 509 
and femurs was obtained by flushing with PBS containing 1 % FCS and depleted of red 510 
blood cells using RBC lysis buffer (Sigma). Stimulation of IFNΥ and IL-17 producing cells 511 
was performed in RPMI media (RPMI-1640 media containing penicillin/streptomycin, 50 μM 512 
18 
 
β-mercaptoethanol and 10 % FCS) with 50 ng/ml PMA and 1 μg/ml Ionomycin (Sigma) for 513 
4 h in the presence of GolgiPlug (BD Biosciences). IELs were prepared as described 514 
previously26. For FACS analysis cells were stained with antibodies (Abs) from BD 515 
Pharmingen directed against CD4 (RM4-5), CD8a (53-6.7), TCRβ (H57-597), CD24 (M1/69), 516 
CD5 (53-7.3), CD25 (PC61), Foxp3 (MF23), Ki67 (B56), IL-7Rα (A7R34), CD44 (IM7), 517 
CD62L (MEL-14), B220 (RA3-6B2), IFNγ (XMG1.2), IL-17A (TC11-18H10), CD45RB (16A), 518 
CD45.1 (A20), CD45.2 (104), CD69 (H1.2F3), and Ly6C (AL-21) and with Abs from 519 
eBioscience directed against NK1.1 (PK136), CD3e (500A2), CCR7 (4B12), CD11b (M1/70), 520 
αβTCR specific for the H-Y antigen (T3.70), Foxp3 (FJK-16s), MHCII (M5/114.15.2), Ly6G 521 
(RB6-8C5), CD115 (AFS98), CD11c (N418), and γδ TCR (UC7-13D5). Intracellular Foxp3 522 
was stained using the BD Pharmingen mouse Foxp3 buffer set or the eBioscience Foxp3 523 
staining buffer set, intracellular IL-17 and IFNΥ using the eBioscience Foxp3 staining buffer 524 
set. Expression of surface and intracellular markers was analyzed using a flow cytometer 525 
(BD FACSCanto™ II) and FlowJo software. 526 
 527 
T-cell stimulation, expansion and apoptosis. 528 
Freshly isolated thymocytes were prepared as described above and plated at 1x106 cells/ml 529 
in round-bottom 96-well plates in RPMI media. Thymocytes were stimulated with plate-bound 530 
anti-mouse CD3e (145-2C11) and 2 μg/ml anti-mouse CD28 (37.51) from eBioscience, 531 
100 U/ml recombinant murine IL-2 (ImmunoTools), or 10 ng/ml PMA and 100 ng/ml 532 
Ionomycin as indicated. Apoptosis was determined using the FITC Annexin V apoptosis 533 
detection kit from BD Pharmingen™. Proliferation was assessed using the PE mouse anti-534 
human Ki-67 set from BD Pharmingen™. For peripheral T-cell expansion, CD4+ T-cells from 535 
spleen were enriched as described above and cultured for 48 h in RPMI-1640 media with 536 
10 % FCS on 6-well plates coated with anti-hamster IgG1 (clone G94-56, BD Pharmingen) in 537 
the presence of soluble anti-mouse CD3e (1 μg/ml) and anti-mouse CD28 (1 μg/ml). 538 
Subsequently, cells were diluted into medium containing IL-2 at a concentration of 100 U/ml. 539 
If the cells were treated with 4-hydroxytamoxifen (OHT, Sigma), OHT was added to a final 540 
concentration of 1 μM. For the stimulation and preparation of protein lysates, thymocytes or 541 
CD4+ T-cells were starved in RPMI-1640 media without FCS for 2 h and activated by 542 
preincubation with soluble anti-mouse CD3ε (10 μg/ml) and anti-mouse CD28 (2 μg/ml) on 543 
ice for 30 min followed by stimulation at 37ºC with prewarmed anti-hamster IgG1 (5 μg/ml, BD 544 
Pharmingen) for the times indicated. Z-Vad (R&D Systems) was used at a final concentration 545 
of 40 μM. 546 
  547 
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 548 
Cell lines, expression constructs and transfection. 549 
Jurkat-derived GADS-deficient cells were described recently49. USP8, GADS and 14-3-3β 550 
expression constructs were generated from human cDNA. C-terminally FLAG-tagged USP8 551 
was expressed using the pFLAG-CMV5α vector; C-terminally HA-tagged 14-3-3β and N-552 
terminally HA-tagged GADS using pcDNA3.1 vectors. Retroviral expression vectors for N-553 
terminally E-tagged (ETAG-)USP8 were generated from mouse cDNA using MIEG3 vector. 554 
Retroviral particles were produced in Platinum-E retroviral packaging cells according to 555 
standard protocols. Point mutations were generated by site-directed mutagenesis using the 556 
QuikChange® mutagenesis system (Stratagene). The Flag-ubiquitin-pCAGGS vector was a 557 
kind gift from the laboratory of Rudi Beyaert, Ghent University. HEK293T-cells were 558 
transfected using FuGENE HD Transfection Reagent from Roche and harvested 36 h post 559 
transfection. 560 
 561 
Western blotting, TCR signalosome purification and immunoprecipitation. 562 
Lymphocytes, thymocytes and HEK293T cells were lysed in n-Dodecyl-β-D-maltoside (DDM) 563 
lysis buffer (50 mM Tris-HCl, pH 7,4; 150 mM NaCl; 1 mM EDTA; 50 mM NaF; 1 mM sodium 564 
vanadate; 1x Roche complete protease inhibitor cocktail; 0.2% DDM). Immunoprecipitations 565 
(IPs) were performed using anti-FLAG M2 affinity gel from Sigma or rat monoclonal anti-HA 566 
antibody (Ab) (clone 3F10) affinity matrix from Roche. Direct IP was performed using the 567 
Pierce® Direct IP kit according to the manufacturer’s protocol. The TCR signalosome was 568 
purified as described before50, except for the additional use of Dynabeads® Mouse T-569 
activator CD3/CD28 beads (Lifetechnologies) and the replacement of 600 mM KCl with 570 
600 mM NaCl during the last two washing steps with “freeze-thaw” buffer. WB analysis was 571 
performed with Abs from Santa Cruz Biotechnology directed against GADS (UW40, 73652), 572 
STAM2 (F-11, 365600), 14-3-3β (H-8, 1657), CD3ε (M20, 1127), PLCγ1 (1F1, 58407), SLP76 573 
(H300, 9062), and Actin (I19, 1616); with Abs from Sigma directed against tubulin (clone 2-574 
28-33, T5293) and Flag (M2); with Abs from Cell Signaling Technology directed against 575 
phospho-p44/42 (197G2, 4377), phospho-JNK (81E11, 4668), phospho-p38 (3D7, 9215), 576 
phospho-AKT (9271), phospho-IκBα (14D4, 2859), IκBα (9242), FoxO1 (C29H4, 2880), 577 
SLP76 (4958),  phospho-SLP76 (S376, 13177), phospho-LAT (Y191, 3584), phospho-PLCγ 578 
(Y783, 2821), K48-linkage specific polyubiquitin (D9D5, 8081), and K63-linkage specific 579 
polyubiquitin (D7A11, 5621); with Abs from abcam directed against Themis (101038) and the 580 
E-tag (10B11, ab3397); with peroxidase-coupled anti-HA Ab (3F10, Roche), anti-LAT Ab (06-581 
807, Millipore), anti-phosphotyrosine Ab (PY20, BD Biosciences, 610000) or peroxidase-582 
coupled anti-phosphotyrosine Ab (4G10, Millipore), and anti-GRAIL Ab (synonym: RNF128, 583 
EPR7426(2), abcam 137088). The peptide affinity-purified polyclonal USP8 Ab raised 584 
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against amino acids (aa) 19-32 of mouse USP8 was kindly provided by Dr. Stephan Feller, 585 
University Clinic Halle (Saale). The X39 Ab raised against aa 542-660 of mouse USP8 was 586 
kindly provided by Dr. Enzo Martegani, University of Milano-Bicocca. Densitometric analysis 587 
was performed using ImageJ software. 588 
 589 
Ca2+ influx. 590 
DP thymocytes were enriched as described above. Thymocytes were starved and loaded 591 
with indo-1-AM (5 μg/ml) for 30 min at 37ºC in RPMI-1640 media without FCS. Subsequently, 592 
thymocytes were incubated with soluble anti-mouse CD3e (10 μg/ml) and anti-mouse CD28 593 
(2 μg/ml) in RPMI-1640 media containing 10% FCS on ice for 20 min and stimulated at 37ºC 594 
with pre-warmed anti-hamster IgG. The emission wavelength ratios of intracellular 595 
Ca2+-bound and -unbound indo-1-AM were analyzed on a LSR II flow cytometer using FACS 596 
Diva software (BD Biosciences). 597 
 598 
Preparation of nuclear extracts and EMSA. 599 
Nuclear extracts were harvested as described previously51. The EMSA was performed using 600 
the Odyssey Infrared EMSA kit and NF-κB and AP-1 probes from LI-COR.  601 
 602 
ChIP assay. 603 
Chromatin IP (ChIP) assays were done using the Millipore ChIP Assay kit according to the 604 
manufacturer’s instructions. CD4+ thymocytes were isolated using BD IMag™ anti-mouse 605 
CD4 magnetic particles-DM (BD Biosciences). Sonication of fixed and lysed cells was 606 
performed using a Branson sonifier cell disruptor B15 (output intensity: 4; 10 x 12 pulses at 607 
90% duty cycle). IP was performed using anti-FKHR Ab (H128, Santa Cruz) or rabbit IgG 608 
(control)19. PCR (Tm= 62ºC; 35 cycles) was performed with the Il7ra-ECR2 S and Il7ra-ECR2 609 
AS primers reported previously19. 610 
 611 
ELISA and Luminex assay. 612 
IL-17 serum concentrations were determined using the mouse IL-17 DuoSet ELISA kit (R&D 613 
Systems); mouse IL-10 concentrations using the Quantikine ELISA kit (R&D Systems). IFNγ, 614 
TNFα, IL-6, IL-12p70, IL-4 and IL-5 serum levels were quantified using the ProcartaPlex™ 615 
Mouse Th1/Th2 essential 6plex Immunoassay (eBioscience). 616 
 617 
Histology. 618 
H&E and immune histological staining of colonic sections with Abs directed against CD3 and 619 
Foxp3 were carried out as described previously52. Immunofluorescence of cryo-sections was 620 
performed using the TSA Cy3 system (PerkinElmer), a fluorescence microscope (IX70; 621 
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Olympus) and primary Abs against CD11c (HL3, BD Biosciences), MPO (15484, Abcam), 622 
and F4/80 (BM8, eBioscience). In brief, cryo-sections were fixed in ice-cold acetone for 10 623 
minutes followed by sequential incubation with methanol, avidin/biotin (Vector Laboratories), 624 
and protein blocking reagent (Dako). Slides were then incubated overnight with primary Abs. 625 
Subsequently, the slides were incubated for 30 minutes at room temperature (RT) with 626 
biotinylated secondary Abs (Dianova). All samples were finally treated with streptavidin-627 
horseradish peroxidase and stained with tyramide (Cy3) according to the manufacturer's 628 
instructions (Perkin Elmer). Before examination, nuclei were counterstained with Hoechst 629 
3342 (Invitrogen). Histological staining of splenic and thymic paraffin sections were carried 630 
out using Abs directed against CD3 (1:100, Serotec, MCA1477), B220 (1:200, BD 631 
Pharmingen 557390), MAC-3 (1:200, BD Pharmingen 553322), and Ki67 (1:50, DAKO 632 
M7249). 633 
 634 
Endoscopy. 635 
For in vivo mini-endoscopy analysis of colons, a high-resolution video endoscopic system 636 
(Karl Storz) was used. To determine colitis activity, mice were anesthetized by injecting a 637 
mixture of ketamine (Ketavest 100 mg/ml, Pfizer) and xylazine (Rompun 2%, Bayer 638 
Healthcare) i.p. and monitored by mini-endoscopy. Endoscopic scoring of five parameters 639 
(translucency, granularity, fibrin, vascularity and stool) was performed. 640 
 641 
In vitro and in vivo Treg assay. 642 
For the preparation of CD4+CD45RBhiCD25- naïve and CD4+CD45RBloCD25+ regulatory T-643 
cells, cell suspensions were prepared from spleens and MLNs and CD4+ T-cells were 644 
enriched as described above and stained. Naïve T-cells and Tregs were isolated by cell 645 
sorting. 5x104 USP8f/f CD4+CD45RBhiCD25- responding T-cells (Tresp) were labeled with 646 
CFSE and cultured with CD4+CD45RBloCD25+ USP8f/f or USP8f/fCD4-Cre  Treg cells at a ratio 647 
1:1, or without Treg cells for 72 h after stimulation with anti-CD3 Ab (2 μg/ml) in the presence 648 
of 1x105 irradiated splenocytes (30 Gy). The division of Tresp cells was assessed by dilution 649 
of CFSE (Molecular Probes™).  650 
For the analysis of in vivo Treg function, Rag1-/- mice were intraperitoneally injected 651 
with 4x105 USPf/f naïve T-cells in the absence or presence of 1x105 USP8f/f (WT) or 652 
USP8f/fCD4-Cre (KO) Tregs. Mice were analyzed 9 weeks post injection. 653 
 654 
Generation of BM chimera. 655 
CD45.1+ mice were irradiated with a dose of 7 Gy and cotrimoxazol was added to the 656 
drinking water. The next day BM was prepared from donor mice as described above and 657 
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mice were intravenously injected with 5-10 x 106 cells (1:2 mixture of BM from CD45.1+ and 658 
CD45.2+USP8f/f or CD45.2+USP8f/fCD4-Cre mice). The reconstituted mice were kept on 659 
antibiotics for 2 weeks and analyzed after 5-8 weeks. 660 
 661 
Tamoxifen-induced in vivo gene deletion 662 
5 mg tamoxifen was applied by gavage on 5 consecutive days. Mice were analyzed after 4 663 
weeks. 664 
 665 
Hematopoietic stem cell transduction and adoptive transfer 666 
BM cells were isolated from USP8f/fCD4-Cre mice that were treated with 5-fluorouracil (150 667 
mg/kg) for 72 h. After removal of red blood cells using lysis buffer, they were cultured in 668 
IMDM with 15% FCS in the presence of recombinant murine stem cell factor (50 ng/ml), 669 
recombinant murine IL-3 (20 ng/ml), and recombinant human IL-6 (50 ng/ml) (R&D Systems) 670 
for 48 h. On day 3 and 4 post isolation, 90’ spin infections (1000g, 30ºC) were performed with 671 
retroviral supernatant in the presence of polybrene (5μg/ml) and cytokines. Cells were 672 
incubated for additional 4 h before medium was replaced. On day 5, 3x105 cells were 673 
injected into the eye vein of lethally irradiated (7Gy) Rag1-/- mice. 674 
 675 
Microarray processing and data analysis. 676 
RNA was isolated from sorted DP thymocytes using the RNeasy Mini kit (Quiagen) and RNA 677 
integrity was verified with a 2100 Bioanalyzer (Agilent Technologies). The samples were 678 
further processed for transcriptome analyses with the Agilent 4 × 44K whole mouse genome 679 
oligo expression microarray kit (Design ID 014868) according to the Agilent One-Color 680 
Microarray-Based Gene Expression Analysis protocol. The raw data were analyzed using 681 
GeneSpring GX 10.0 (normalization: shift to 75th percentile, baseline transformation: median 682 
of all samples). The normalized data were filtered to exclude probes flagged absent in all 683 
samples. The remaining probes were tested for statistical significance of expression using a 684 
two-sample Student’s t-test (unpaired) with asymptotic p-value computation and a cut off of 685 
0.05. Multiple testing correction was performed according to Benjamini Hochberg53 (P ≤ 686 
0.05). The cutoff for the fold change is ≤ 2 (1 log2) up or down regulation. 687 
  688 
Mass spectrometry (MS) analysis. 689 
Protein IPs were generated from transfected HEK293T cells as described above, denatured 690 
in Laemmli buffer in the presence of 50 mM DTT and treated with 120 mM iodoacetamide 691 
(IAA, Sigma) for 10 minutes at RT maintaining neutral pH in the dark, followed by quenching 692 
with 40 mM DTT for 20 minutes in the dark. Subsequently, proteins were separated by SDS-693 
PAGE and the protein band corresponding to the accumulated ubiquitin-modified 14-3-3β 694 
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molecule was excised. For in-gel digestion the excised gel band was destained with 30 % 695 
ACN, shrunk with 100 % ACN, and dried in a Vacuum Concentrator (Concentrator 5301, 696 
Eppendorf, Hamburg, Germany). Digests with trypsin and thermolysin were performed 697 
overnight at 37°C in 0.05 M NH4HCO3 (pH 8). About 0.1 µg of protease was used for one gel 698 
band. Peptides were extracted from the gel slices with 5 % formic acid. The digests were 699 
analyzed by nanoLC-MS/MS on a Q-TOF mass spectrometer (Agilent 6520, Agilent 700 
Technologies) and on a 6340 ion trap equipped with an ETD II source (Agilent 701 
Technologies). Both instruments were coupled to a 1200 Agilent nanoflow system via a 702 
HPLC-Chip cube ESI interface. Peptides were separated on a HPLC-Chip with an analytical 703 
column of 75 µm i.d. and 150 mm length and a 40-nL trap column, both packed with Zorbax 704 
300SB C-18 (5 µm particle size). Peptides were eluted with a linear acetonitrile gradient with 705 
1 %/min at a flow rate of 300 nL/min (starting with 3% acetonitrile). 706 
The Q-TOF was operated in the 2 Ghz extended dynamic range mode. MS/MS analyses 707 
were performed using data-dependent acquisition mode. After a MS scan (2 spectra/s), a 708 
maximum of three peptides were selected for MS/MS (2 spectra/s). Singly charged precursor 709 
ions were excluded from selection. Internal calibration was applied using two reference 710 
masses. 711 
ETD analyses on the ion trap were performed using data-dependent acquisition mode. 712 
After a MS scan (standard enhanced mode), a maximum of three peptides were selected for 713 
ETD-MS/MS (standard enhanced mode). The automated gain control (ICC) for MS scans 714 
was set to 350000. The maximum accumulation time was set to 300 ms. The following ETD 715 
parameters were used. ICC target: 400000, reaction time: 100 ms, cut-off: 140, resonance 716 
excitation (Smart Decomp) was used for doubly charged peptides. 717 
Mascot Distiller 2.3 was used for raw data processing and for generating peak lists, 718 
essentially with standard settings for the Agilent Q-Tof and ion trap. Mascot Server 2.3 was 719 
used for database searching with the following parameters: peptide mass tolerance: 20 ppm 720 
for Q-Tof data and 1.1 Da for ion trap data, MS/MS mass tolerance: 0.05 Da for Q-Tof data 721 
and 0.3 Da for ion trap data, enzyme: “trypsin” with 3 uncleaved sites allowed for trypsin, and 722 
“none” for thermolysin, variable modifications: Carbamidomethyl  (C), Gln->pyroGlu (N-term. 723 
Q), and oxidation (M) were used for all searches. In addition GG (K) and LRGG (K) were 724 
used as variable modifications for the identification of ubiquitination sites in the tryptic digest, 725 
and LRGG (K), LRLRGG (K) and VLRLRGG (K) were used for the thermolysin digest 726 
(thermolysin cleaves N-terminal of the amino acids L, I, F, A and V). For protein and peptide 727 
identification a custom database containing the protein sequences of 14-3-3β was used. All 728 
MS/MS spectra identified as ubiquitinated peptides were validated manually. 729 
 730 
  731 
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Statistical Analysis  732 
We ensured that our sample sizes matched those generally employed in the field. Data were 733 
tested for normality applying the Kolmogorov-Smirnov test. If normality was given, a t-test 734 
was applied. Differences were considered significant for p values < 0.05. 735 
 736 
Accession Code. 737 
Microarray data were submitted to the GEO database (accession number: GSE55517). 738 
739 
25 
 
Figure legends 740 
 741 
Figure 1. USP8 interacts with GADS, 14-3-3β and the TCR signalosome. (a,b) HEK293T-742 
cells were transfected with control or expression vectors for affinity-tagged USP8 and GADS 743 
(a) or 14-3-3β (b) as indicated. Anti-FLAG IP was performed. Lysates and precipitated 744 
proteins were analyzed by WB. The amount of precipitated GADS relative to the amount of 745 
precipitated USP8 was determined by densitometric analysis. Results shown are the means 746 
of 4 independent experiments ±SEM. **, p<0.01; ***, p<0.001 (unpaired, two-sided t-test). (c) 747 
Interaction of endogenous USP8 and GADS. Splenic CD4+ WT T-cells were expanded for 4 748 
days. Consequently, cells were starved, restimulated with anti-CD3/anti-CD28 Abs and 749 
lysed. Direct IP was performed with anti-USP8(X39) Ab. Lysates and precipitates were 750 
analyzed by WB. The amount of proteins present in the IP relative to the unstimulated control 751 
was determined by densitometric analysis. (d) HEK293T-cells were transfected with USP8-752 
FLAG expression vectors. IP was performed and analyzed as in (a) using anti-FLAG and 753 
anti-14-3-3β Abs. (e) USP8 binds to TCR/CD28 signalosomes. CD4+ T-cells were expanded 754 
as in (c). Signalosomes were purified after restimulation with Dynabeads® Mouse T-Activator 755 
CD3/CD28. Input and signalosome-associated proteins were analyzed by WB. (f) USP8 is 756 
processed upon TCR activation. CD4+ T-cells were expanded and restimulated as in (c). Cell 757 
lysates were analyzed by WB. (g) Inhibition of USP8 processing in the presence of z-VAD. 758 
(h) USP8 modulates GADS and 14-3-3β ubiquitination. HEK293T-cells were transfected with 759 
the indicated vectors and lysates were analyzed as in (a). Experiments in Fig. 1 are 760 
representative of at least 3 independent trials. 761 
 762 
Figure 2. Altered T-cell development in USP8f/fCD4-Cre mice. (a) USP8 expression in 763 
USP8f/fCD4-Cre thymocytes. Protein lysates were generated from USP8f/f and USP8f/fCD4-764 
Cre  DP thymocytes. USP8 and Actin protein levels were determined by WB. (b) Left panels: 765 
Flow cytometric analysis of CD4 and CD8 expression on thymocytes derived from USP8f/f, 766 
USP8f/fCD4-Cre, and USP8+/+CD4-Cre mice. Right panels: Total numbers of thymocyte 767 
subsets derived from 9-week-old USP8f/f and USP8f/fCD4-Cre female mice. Results shown 768 
are the means of 3 independent experiments ±SEM and are representative of at least 3 769 
independent trials. (c) Histology of thymi stained with hematoxilin and eosin (H&E). Scale 770 
bar: 400 μm. (d) Diminished thymic Treg and NKT levels. Left panel: percentages of 771 
CD25+Foxp3+ Tregs within the CD4+ thymocyte population derived from USP8f/f and 772 
USP8f/fCD4-Cre mice. Right panel: Representative flow cytometric analysis of NK1.1+/TCRβ+ 773 
NKT-cells. Results shown are the means of 3 independent experiments ±SD. (e) Flow 774 
cytometric analysis of the surface markers TCRβ, CD69, CD62L, CD24 and CD5 on 775 
thymocyte subsets derived from USP8f/f and USP8f/fCD4-Cre mice. Results shown are 776 
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representative of at least 6 independent experiments. DP, CD4/CD8 double positive; DN, 777 
CD4/CD8 double negative; SP4, CD4 single positive; SP8, CD8 single positive. *, p<0.05; **, 778 
p<0.01; ***, p< 0.001 (unpaired, two-sided t-test). 779 
 780 
Figure 3. Diminished thymocyte proliferation upon USP8 depletion. (a) Impaired 781 
responsiveness of USP8f/fCD4-Cre thymocytes to TCR- and PMA/IONO-induced 782 
proliferation. Thymocytes derived from USP8f/f and USP8f/fCD4-Cre mice were stimulated for 783 
72 h with plate-bound anti-CD3 Ab in the absence or presence of anti-CD28 Ab or IL-2, or 784 
with PMA/IONO. Expression of Ki67 and TCRβ were monitored by FACS analysis (left 785 
panels). Cell numbers were monitored in parallel (middle panel). Correlation of TCR and Ki67 786 
expression is shown in the right panel for anti-CD3/CD28-stimulated thymocytes. Results are 787 
representative of at least 3 independent trials. (b) Impaired IL-2 production. Thymocytes 788 
derived from USP8f/f and USP8f/fCD4-Cre mice were stimulated with plate-bound anti-CD3 Ab 789 
for 72h. IL-2 concentrations were determined in supernatants of stimulated cells and 790 
unstimulated controls. Results shown are the means of 3 independent experiments ±SD. *, 791 
p< 0.05 (unpaired, one-sided t-test). (c) Impairment of positive, but not negative thymic 792 
selection in USP8f/fCD4-CreHY-TCR+ mice. Flow cytometric analysis of CD4 and CD8 793 
expression on HY-TCR-positive thymocytes derived from 7-8-week-old female (upper 794 
panels) and male (lower panels) USP8f/fHY-TCR+ and USP8f/fCD4-CreHY-TCR+ mice. 795 
Results shown are one trial representative of at least 3 independent experiments. 796 
 797 
Figure 4. Signaling defects in USP8f/fCD4-Cre thymocytes. (a) Left panels: Flow 798 
cytometric analysis of IL-7Rα and CCR7 expression on thymocyte subsets derived from 799 
USP8f/f and USP8f/fCD4-Cre mice. Results are representative of at least 3 independent 800 
experiments. Right panel: Relative IL-7Rα, CCR7 and CCND2 RNA expression in DP 801 
USP8f/fCD4-Cre thymocytes. RNA expression was measured by quantitative real-time PCR 802 
analysis. Results shown are the mean mRNA levels in DP USP8f/fCD4-Cre thymocytes 803 
relative to DP USP8f/f thymocytes ±SD for 4 independent experiments (p<0.001, unpaired, 2-804 
sided t-test). (b) Foxo1 expression in USP8f/fCD4-Cre thymocytes. Protein lysates were 805 
generated from anti-CD4-purified USP8f/f and USP8f/fCD4-Cre thymocytes. Foxo1 and Actin 806 
protein levels were determined by WB. (c) CHIP analysis of Foxo1 binding to the Il7r locus in 807 
anti-CD4-purified USP8f/f and USP8f/fCD4-Cre thymocytes. The data shown are 808 
representative of 3 independent experiments. 809 
 810 
Figure 5. USP8f/fCD4-Cre mice exhibit lymphopenia and hyperactivation of peripheral 811 
T-cells. (a) Left: Representative flow cytometric analysis of lymphocyte subsets in spleen 812 
derived from USP8f/f, USP8+/+CD4-Cre and USP8f/fCD4-Cre mice. Percentages of CD3, 813 
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B220, CD4 and CD8 positive subsets are indicated. Percentages of CD44 and CD62L 814 
expression are shown for CD3+CD4+ lymphocytes. Right: Specific reduction of T-cell 815 
numbers in the spleen of USP8f/fCD4-Cre mice. Total numbers of T- (CD3+) and B-cells 816 
(B220+) derived from USP8f/f and USP8f/fCD4-Cre mice are shown. (b) Relative numbers of 817 
cells indicate Tregs (CD25+Foxp3+) referring to CD4+cells; granulocytes (Ly6G+CD11b+) and 818 
monocytes (CD115+CD11b+) referring to CD3- cells, plasmacytoid dendritic cells 819 
(CD11cloB220+) referring to CD3-Ly6C+CD11b- cells and conventional dendritic cells 820 
(CD11chiLy6C-) referring to CD3-MHCII+ cells. (c) Flow cytometric analysis of Tregs and 821 
pDCs in MLNs. Percentages are indicated as in (b). Results shown in a-c are the means of 6 822 
independent experiments ±SD. (d) Cytokine profile of PMA/IONO-stimulated CD4+ T-cells 823 
from spleen. IFNγ and IL-17 expression were monitored by intracellular staining and FACS 824 
analysis. (e) Flow cytometric analysis of the markers TCRβ, CD25, CD45RB and CD69 on 825 
CD4+ (and TCRβ+ where indicated) lymphocytes derived from spleen and MLNs of USP8f/f or 826 
USP8f/fCD4-Cre mice. Results shown in (d) and (e) are representative of at least 3 or 6 827 
independent experiments, respectively. Tregs, regulatory T-cells; GCs, granulocytes; MCs, 828 
Monocytes; pDCs, plasmacytoid dendritic cells; cDCs, conventional dendritic cells. **, 829 
p<0.01; ***, p< 0.001 (unpaired, two-sided t-test). 830 
 831 
Figure 6. T-cell specific USP8-deficiency causes lethal colitis. (a) Macroscopic images of 832 
bowel prolapses and intestines of USP8f/f and USP8f/fCD4-Cre mice (upper left panels). 833 
Endoscopic recording (upper right panel), colons (lower left panel), and spleens and MLNs 834 
(lower right panel) of USP8f/f and diseased USP8f/fCD4-Cre mice. (b) Survival curve of WT 835 
control mice and USP8f/fCD4-Cre mice. (c) Left panels: Histology of colons from mice of the 836 
indicated genotypes stained with H&E, anti-CD3 Ab (pink) and anti-Foxp3 Ab (brown). 837 
Arrows indicate crypt abscess (top) and the presence of Foxp3+ Tregs (bottom). Right 838 
panels: Colonic cryo-sections of mice of the indicated genotypes were immunostained with 839 
anti-CD11c, anti-myeloperoxidase (MPO) and anti-F4/80 Abs (red) to detect DCs, neutrophils 840 
and macrophages, respectively. Nuclei were counterstained with Hoechst 3342 (blue). Scale 841 
bar: 200 μm. (d) Histological analysis of splenic cell populations causing splenomegaly. H&E 842 
staining and labeling with anti-CD3, anti-B220, anti-Mac-3, and anti-Ki67 Abs was performed 843 
on splenic paraffin sections as indicated. Scale bar: 200 µm. 844 
 845 
Figure 7. Intrinsic function of USP8 is critical for T-cell homeostasis. (a) Disturbed T-cell 846 
homeostasis upon peripheral USP8 deletion. Six week-old RAG2/Il2rg KO mice were 847 
intravenously injected with 12.5 x 106 splenocytes of the indicated genotypes. At day 4 post 848 
injection, mice were subjected to tamoxifen-induced gene deletion. On day 23 post injection, 849 
splenocytes were analyzed by FACS. Results are representative of 5 independent 850 
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experiments. (b) T-cell defect in mixed CD45.1+WT/CD45.2+USP8f/fCD4-Cre BM chimeras. 851 
Reconstitution efficiency of the indicated T-cell subsets was monitored. Splenic CD4+ T-cells 852 
were also stained for intracellular IFNγ and IL-17 upon PMA/IONO treatment. Data are 853 
representative of 3 independent experiments. (c) Time course of OHT-induced deletion of 854 
USP8. CD4+ T-cells were enriched from spleens, stimulated with anti-CD3/anti-CD28 Abs in 855 
the presence of plate-bound anti-hamster Ab for 48 h and with IL-2 in the presence of OHT 856 
for the times indicated. Cells were analyzed for USP8 expression by WB and for CD3, CD4, 857 
CD8, and Ki67 expression by FACS. The results are representative of at least 3 independent 858 
experiments. (d) Essential role of USP8 catalytic activity and SH3 binding capacity. RAG1-/- 859 
mice were reconstituted with USP8f/fCD4-Cre BMSCs transduced with retroviral particles 860 
expressing the indicated USP8 variants and eGFP. Mice were analyzed 8 weeks later for 861 
efficiency of CD4+/eGFP+ lymphocyte reconstitution. Results are representative of 3 862 
independent experiments. Means ±SEM are shown in the middle panel. **, p<0.01; ***, 863 
p<0.001 (unpaired, 2-sided t-test). Right panel: Retroviral expression of ETAG-USP8 variants 864 
in NIH3T3 cells. 865 
 866 
Figure 8. γδ T-cells promote colitis in the absence of functional Tregs. Dominance of γδ 867 
T-cells in colon epithelium (a) and MLNs (b) of USP8f/fCD4-Cre mice. IELs and MLN cells 868 
were prepared from USP8f/f and diseased USP8f/fCD4-Cre mice and analyzed by FACS. The 869 
data shown are representative of 2 independent experiments. (c) Total numbers of αβ and γδ 870 
T-cells in MLNs of 12-week-old USP8f/f or USP8f/fCD4-Cre mice, or CD45.1+WT/ 871 
CD45.2+USP8f/fCD4-Cre BM chimera (normalized to 100% reconstitution efficiency for each 872 
genotype). ***, p<0.001 (unpaired, two-sided t-test). (d) Cytokine levels in serum from aged 873 
USP8f/f and USP8f/fCD4-Cre mice with overt signs of colitis. *, p<0.05 (unpaired, two-sided t-874 
test). (e) Lack of in vivo Treg function. Rag1-/- mice were injected with USP8f/f naïve T-cells 875 
in the absence or presence of USP8f/f (WT) or USP8f/fCD4-Cre (KO) Tregs. After 9 weeks, 876 
splenic CD4+ cell were analyzed for Foxp3 expression. Colons were analyzed 877 
macroscopically and by H&E staining of distal paraffin sections. Results are representative of 878 
at least 3 independent experiments. (f) Lack of in vitro Treg function. Division of anti-CD3-879 
stimulated Tresp cells cultured in the presence or absence of USP8f/f or USP8f/fCD4-Cre Treg 880 
cells was assessed by dilution of CFSE. Data are representative of 2 independent 881 
experiments, each performed in triplicates with cells derived from 4 USP8f/f mice and 10 882 
USP8f/fCD4-Cre mice. (g) Deregulated IFNγ response in splenic USP8f/fCD4-Cre Tregs. IFNγ 883 
expression in PMA/IONO-stimulated CD4+Foxp3+ splenocytes from 7-week-old USP8f/f and 884 
USP8f/fCD4-Cre mice. Results are representative of 5 independent experiments. **, p<0.01 885 
(paired, 2-sided t-test). 886 
  887 
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Supplementary Figure Legends 888 
Supplementary Figure S1. Identification of USP8-interacting proteins by Y2H 889 
screening. (a) Schematic representation of USP8 baits: Bait 1 (residues 143 – 485 of human 890 
USP8) encodes the N-terminal SH3BM. Bait 2 (residues 481-764) harbors the 14-3-3BM and 891 
the C-terminal SH3BM. (b) NMY51 cells were cotransformed with vectors encoding bait 1 or 892 
2 and either GADS or 14-3-3β. The interaction between the proteins was confirmed by yeast 893 
growth on agar plates lacking tryptophane, leucine and histidine (-TLH) and by β-894 
Galactosidase assay (X-Gal). As a control, LaminC was coexpressed with GADS and 14-3-895 
3β, respectively. 896 
 897 
Supplementary Figure S2. USP8 modulates GADS and 14-3-3β ubiquitination. (a) 898 
HEK293T-cells were transfected with an empty vector or expression vectors for FLAG-899 
tagged USP8 and/or FLAG-tagged ubiquitin, HA-tagged GADS or HA-tagged 14-3-3β as 900 
indicated on the top. IP was performed with anti-HA(3F10) Ab. Lysates were immunoblotted 901 
with anti-FLAG and anti-HA(3F10) Abs, precipitated proteins with anti-HA(3F10) Ab. *, 902 
ubiquitin modification. Results are representative of 2 independent experiments. (b) MS 903 
analysis of 14-3-3β ubiquitination sites. Flag-tagged USP8(C786A) was cotransfected with 904 
FLAG-ubiquitin and HA-tagged 14-3-3β in 293HEK cells. An anti-HA-IP was performed and 905 
the isolated proteins were separated by SDS-PAGE. A protein band corresponding to the 906 
accumulated ubiquitin-modified 14-3-3β molecule was excised and analyzed as described in 907 
Materials and Methods. Briefly, proteins were digested in gel in separate experiments with 908 
trypsin and with thermolysin. Both digests were analyzed with CID on a Q-TOF instrument 909 
and with ETD on an ion trap instrument. The peptide MDKSELVQKAK generated in the 910 
thermolysin digest was identified on both instruments with an N-terminal acetylation, an 911 
oxidized methionine and with a lysine linked to LRGG. The shown ETD spectrum allows 912 
unambiguous localization of the ubiquitination site to K-9. The peptide VFYYEILNSPEKACS 913 
(also generated in the thermolysin digest) was identified by CID on the Q-Tof instrument with 914 
a carbamidomethylated cysteine and a LRGG-modified lysine residue. The shown CID 915 
spectrum allowed unambiguous localization of the ubiquitination site to position 189. 916 
 917 
Supplementary Figure S3. Consequences of USP8 gene deletion in thymocytes. (a) 918 
Verification of USP8 gene deletion in thymocytes of USP8f/fCD4-Cre mice by Southern blot 919 
analysis. Genomic DNA from sorted thymocytes derived from WT and USP8f/fCD4-Cre mice 920 
was digested with NcoI and analyzed using a 32P-labeled probe. Efficient deletion is indicated 921 
by appearance of the 6 kb KO band at the expense of the 5 kb band representing the floxed 922 
allele. (b) USP8 protein expression in thymocyte subsets of USP8f/f (c) and USP8f/fCD4-Cre  923 
(KO) mice. DN, SP4 and SP8 thymocyte subsets were sorted for WB analysis. (c) USP8 924 
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protein expression in thymocyte subsets of USP8f/f (c) and USP8f/fLCKCre (KO) mice. DN, DP, 925 
SP4 and SP8 thymocyte subsets were sorted for WB analysis. (d) CD25 and CD44 926 
expression on DN thymocytes for analysis of the early DN1 (CD44+CD25-), DN2 927 
(CD44+CD25+), DN3 CD(CD44-CD25+) and DN4(CD44-CD25-) stages of thymocyte 928 
development. (e) Developmental defect in USP8f/fLCKCre thymocytes. Upper panels: Flow 929 
cytometric analysis of CD4 and CD8 expression on thymocytes derived from USP8f/f and 930 
USP8f/fLCKCre mice. Lower panels: TCRβ expression on thymocyte subsets of USP8f/f and 931 
USP8f/fLCKCre mice. Results in (d) and (e) are representative of 3 independent experiments. 932 
(f) Thymocyte survival assay. Thymocytes derived from USP8f/f and USP8f/fCD4-Cre mice 933 
were stimulated as in figure 3a for 48 h and stained with propidium iodide (PI) and a 934 
fluorescent conjugate of Annexin V. The percentages of cells in early apoptosis 935 
(AnnexinV+PI-) and late apoptosis (AnnexinV+PI+) are indicated. Results in (f) are the means 936 
of 3 independent experiments ±SD. 937 
Supplementary Figure S4. Normal TCR signaling in USP8f/fCD4-Cre thymocytes. (a,b) 938 
Normal levels of STAM2 expression and ubiquitination in CD4+ thymocytes. (a) Protein 939 
lysates from thymocytes were analyzed by WB for USP8 and STAM2 expression. (b) Protein 940 
lysates from anti-CD4-purified thymocytes were analyzed by WB for expression levels of 941 
proteins harboring K48-linked and K63-linked ubiquitin chains. (c) Ligand-induced TCR 942 
downmodulation. Thymocytes were stained on ice with biotinylated hamster anti-TCRβ Ab. 943 
Subsequently, the TCR was crosslinked with anti-hamster Ab at 37ºC for the indicated times. 944 
Remaining surface TCR was labeled with streptavidin-PE and measured by FACS in SP4 945 
(left) and DP gates. The percentages of surface expression are presented as the mean 946 
fluorescence values of treated cells, using the untreated controls as reference (n=5). (d-i) 947 
Total thymocytes (d,e,i) or enriched DP thymocytes (f,g,h) were stimulated for the indicated 948 
times with anti-CD3/anti-CD28 Abs. Phosphorylation of ERK1/2, JNK, p38, Akt (d) and IκBα 949 
(e), and Actin protein levels were monitored by WB. In (f), IκBα, 14-3-3β, GADS and Actin 950 
protein levels were monitored by WB. (g,h) NF-κB activation and AP1 activation were 951 
determined by EMSA. (i) Tyrosine phosphorylation was detected by WB with the PY20 anti-952 
phosphotyrosine Ab. Total protein levels correspond to the Actin levels shown in (d). (j) Ca2+ 953 
influx in anti-CD3/anti-CD28-stimulated, enriched DP thymocytes. Thymocytes were loaded 954 
with indo-1-AM (5 μg/ml) and activated with anti-CD3/anti-CD28. The graph shows the ratio 955 
of bound to unbound indo-1-AM as a measure of Ca2+ influx. Results are representative of at 956 
least 3 independent experiments. SFo, surface fluorescence. 957 
Supplementary Figure S5. Microarray analysis of gene expression in DP thymocytes 958 
upon USP8 depletion. (a) Microarray analysis of 2 groups of 2 USP8f/f and 2 USP8f/fCD4-959 
Cre DP thymocyte populations (8 mice in total), which resulted in a list of 74 genes with a 960 
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significant >2-fold difference. The heatmap of the 74 gene list is shown. (b) Top Network 961 
extracted by analysis of the microarray gene expression data using the Ingenuity software. 962 
Supplementary Figure S6. Consequences of USP8 gene deletion in peripheral T-cells. 963 
(a) Representative flow cytometric analysis of lymphocyte subsets in MLNs derived from 964 
USP8f/f, USP8+/+CD4-Cre and USP8f/fCD4-Cre mice was performed as in Fig. 5a (n>6). (b) 965 
USP8 gene deletion in peripheral T-cells from USP8f/fCD4-Cre mice. Southern blot analysis 966 
was performed using sorted CD4+ and CD8+ cells from spleen and MLNs derived from WT 967 
and USP8f/fCD4-Cre mice. (c) Normal USP8 and Foxo1 protein expression in sorted effector 968 
T-cells derived from USP8f/f and USP8f/fCD4-Cre mice. (d) IL7Rα expression on USP8f/fCD4-969 
Cre effector and naïve T-cells. CD3+CD4+ splenocytes were analyzed for CD44, CD62L and 970 
IL7Rα expression to determine IL7Rα expression on effector and naïve T-cell subsets. (n=5; 971 
p=0.006; paired, 2-sided, t-test). (e) Altered T-cell homeostasis in USP8f/fLCKCre mice. 972 
Percentages of CD3+, CD4+, and CD8+ lymphocytes and the distribution of naïve 973 
(CD44loCD62Lhi) and effector T-cells (CD44hiCD62Llo) within the CD3+/CD4+ population were 974 
determined in spleen (n=3). The percentages of IL7Rα expressing naïve T-cells are indicated 975 
in the right panel. Results shown are the means of 4 independent experiments ±SD. **, 976 
p<0.01 (unpaired, 2-sided t-test). (f) Representative FACS analysis of CCR7 expression on 977 
CD4+ splenocytes derived from USP8f/f and USP8f/fCD4-Cre mice (n=3). (g) Upper panels: 978 
Representative IL-7Rα expression on SP4 and SP8 thymocytes derived from BM chimera 979 
reconstituted with CD45.1+ WT and CD45.2+ USP8f/fCD4-Cre cells (n=6). Lower panel: 980 
percentages of IL7Rα expressing naïve T-cells in CD45.1+WT/CD45.2+USP8f/fCD4-Cre BM 981 
chimera. Results shown are the means of 6 independent experiments ±SD. 982 
Supplementary Figure S7. Proximal TCR signaling is not affected by OHT-induced 983 
USP8 deletion. (a-d) CD4+ T-cells were enriched from spleens of USP8+/fCD4-CreERT2 984 
(control) and USP8f/fCD4-CreERT2 (iKO) mice, expanded and treated with OHT for 48 h as in 985 
Figure 7c. Subsequently, cells were starved for 2 h and restimulated with anti-CD3 and anti-986 
CD28 Abs for the times indicated. (a) Assessment of USP8, LAT phospho-LAT, phospho-987 
PLCγ, phospho-ERK1/2 and Actin expression levels by WB. (b) Cells were also pretreated 988 
with MG132 and chloroquine to inhibit proteasomal and lysosomal degradation, respectively. 989 
USP8, GADS, 14-3-3β, phospho-IκBα, and Actin expression were monitored by WB. (c) Cell 990 
lysates were analyzed for Actin and USP8 expression. In parallel, p38- and PKB-991 
phosphorylation was monitored using phospho-specific Abs. (d) Analysis of the levels of 992 
USP8, proteins modified by K48-linked ubiquitination, tyrosine-phosphorylated proteins, 993 
SLP76, SLP76 phosphorylated at S376 (14-3-3BM), phospho-JNK, Foxo1, GRAIL and Actin 994 
by WB. The results shown in Supplementary Fig. 7 are representative of at least 3 995 
independent experiments. 996 
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Supplementary Figure S8. TCR signalosome formation upon OHT-induced USP8 997 
deletion and USP8 binding to the CD3/CD28 cluster in Jurkat-derived KO cells. (a) 998 
CD4+ T-cells were enriched from spleens of USP8+/fCD4-CreERT2 (control) and USP8f/fCD4-999 
CreERT2 (iKO) mice, expanded and treated with OHT for 48 h as in Figure 7c. Subsequently, 1000 
TCR signalosomes were purified after restimulation with Dynabeads® Mouse T-Activator 1001 
CD3/CD28. Total lysate (input) and components of the signaling complex were analyzed by 1002 
WB using Abs directed against USP8, tyrosine-phosphorylated proteins, CD3ε and the 1003 
indicated signaling components. (b) Jurkat-derived GADS- (dG32GADS-/-), LAT- (J.Cam2.5), 1004 
and SLP76 (J14) KO cells were stimulated with Dynabeads® Human T-Activator CD3/CD28 1005 
prior to purification of TCR signalosomes. Antibodies directed against USP8 and TCR-1006 
proximal signaling components were used to analyze the input and purified signalosome 1007 
components. Results are representative of 3 independent experiments. 1008 
Supplementary Movie S1 (3.8Mb). Typical appearance of healthy colon visualized by in 1009 
vivo mini-endoscopic analysis of USP8f/f mouse.  1010 
 1011 
Supplementary Movie S2 (4.1Mb). Endoscopic recording of USP8f/fCD4-Cre colon 1012 
revealing typical signs of colitis like enhanced granularity, loss of the vascular pattern of the 1013 
mucosa and a reduction in translucency. 1014 
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